1Q 2023 Earnings Call Presentation A P RI L 2 6 , 2 0 2 3 Forward-Looking Statements 2 Management uses certain non-GAAP financial measures, most specifically Adjusted EBITDA, as a supplement to GAAP financial measures to further evaluate the company's operating performance period over period, analyze the underlying business trends, assess performance relative to competitors and establish operational objectives. • Stock-based compensation expense – The company excludes non-cash costs related to the company's ...

Nevro Corp. (NYSE:NVRO) Q1 2023 Earnings Conference Call April 26, 2023 4:30 PM ET Company Participants Julie Dewey - Chief Corporate Communications and Investor Relations Officer Keith Grossman - Executive Chairman Kevin Thornal - President and CEO Rod MacLeod - Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Bill Plovanic - Canaccord Allen Gong - J.P. Morgan Adam Maeder - Piper Sandler Mike Sarcone - Jefferies Anthony Petrone - Mizuho Operator Good afternoon. My name is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36715 Nevro Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 56-2568057 (I.R. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 001-36715 NEVRO CORP. (Exact name of registrant as specified in its charter) Delaware 56-2568057 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Iden ...

Nevro Corporation (NYSE:NVRO) Q4 2022 Earnings Conference Call February 16, 2023 4:30 PM ET Company Participants Julie Dewey - Chief Corporate Communications and Investor Relations Officer Keith Grossman - Chairman, CEO and President Rod MacLeod - Chief Financial Officer Conference Call Participants Joanne Wuensch - Citibank Chris Pasquale - Nephron Vik Chopra - Wells Fargo Brandon Vazquez - William Blair Robbie Marcus - J.P. Morgan Dave Rescott - Truist Securities Simran Kaur - Piper Sandler Operator Good ...

Nevro Corporation (NYSE:NVRO) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Julie Dewey - Chief Corporate Communications & IR Officer Keith Grossman - Chairman, CEO & President Roderick MacLeod - CFO Conference Call Participants Simran Kaur - Piper Sandler & Co. Joanne Wuensch - Citi Devin Geiman - Nephron Research David Rescott - Truist Securities Brandon Vazquez - William Blair & Company Nathan Treybeck - Wells Fargo Securities Robert Marcus - JPMorgan Chase & Co. David ...

3Q 2022 Earnings Presentation N O VE M BER 2 , 2 0 2 2 Dania Forward-Looking Statements In addition to historical information, this presentation contains forward-looking statements reflecting the company's current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including: our full year 2022 financial guidance; our belief that we will continue to see a gradual overall trend of SCS market recovery, which we expect to c ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36715 Nevro Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 56-2568057 ( ...

| --- | --- | --- | --- | --- | --- | --- | |----------------------------------------------------------------------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | From Recovery to | | | | | | | | Renewed Growth | | | | | | | | Canaccord Genuity Annual Growth Conference | | | | | | | | R O D M a c LEOD C H I E F F I N A N C I A L O F F I C E R A UG US T 1 0 , 2 0 2 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Forward-Loo ...

Nevro Corp. (NYSE:NVRO) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Julie Dewey - Corporate Communications & IR Officer Keith Grossman - Chairman, President & CEO Roderick MacLeod - CFO Conference Call Participants Larry Biegelsen - Wells Fargo Calvin Chu - Morgan Stanley Simran Kaur - Piper Sandler Robert Marcus - JPMorgan Anthony Occhiogrosso - Citi David Rescott - Truist Securities Margarate Boeye - William Blair Operator Good afternoon. My name is David, and I'll be y ...